EDGAR Filing Documents for 0000950135-09-003622

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950135-09-003622

Filing Date

2009-05-06

Accepted

2009-05-06 07:00:37

Documents

Period of Report

2009-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	IDERA PHARMACEUTICALS, INC.	b75192ipe10vq.htm	10-Q	308738
2	EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULES	b75192ipexv31w1.htm	EX-31.1	6117
3	EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULES	b75192ipexv31w2.htm	EX-31.2	6134
4	EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1	b75192ipexv32w1.htm	EX-32.1	3054
5	EX-32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1	b75192ipexv32w2.htm	EX-32.2	3070
	Complete submission text file	0000950135-09-003622.txt		328605

Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500

IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)